These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Multigene methylation analysis for detection and staging of prostate cancer. Enokida H; Shiina H; Urakami S; Igawa M; Ogishima T; Li LC; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R Clin Cancer Res; 2005 Sep; 11(18):6582-8. PubMed ID: 16166436 [TBL] [Abstract][Full Text] [Related]
6. Radial distance of extraprostatic extension measured by an ocular micrometer is an independent predictor of prostate-specific antigen recurrence: a new proposal for the substaging of pT3a prostate cancer. Epstein JI Am J Surg Pathol; 2008 Feb; 32(2):337-8; author reply 338-40. PubMed ID: 18223339 [No Abstract] [Full Text] [Related]
7. Prostate-specific antigen mRNA and protein levels in laser microdissected cells of human prostate measured by real-time reverse transcriptase-quantitative polymerase chain reaction and immuno-quantitative polymerase chain reaction. Pinzani P; Lind K; Malentacchi F; Nesi G; Salvianti F; Villari D; Kubista M; Pazzagli M; Orlando C Hum Pathol; 2008 Oct; 39(10):1474-82. PubMed ID: 18619642 [TBL] [Abstract][Full Text] [Related]
8. The detection and isolation of viable prostate-specific antigen positive epithelial cells by enrichment: a comparison to standard prostate-specific antigen reverse transcriptase polymerase chain reaction and its clinical relevance in prostate cancer. Pfitzenmaier J; Ellis WJ; Hawley S; Arfman EW; Klein JR; Lange PH; Vessella RL Urol Oncol; 2007; 25(3):214-20. PubMed ID: 17483018 [TBL] [Abstract][Full Text] [Related]
9. Reverse transcriptase-polymerase chain reaction and immunohistochemical studies for detection of prostate stem cell antigen expression in prostate cancer: potential value in molecular staging of prostate cancer. Joung JY; Yang SO; Jeong IG; Han KS; Seo HK; Chung J; Park WS; Lee KH Int J Urol; 2007 Jul; 14(7):635-43. PubMed ID: 17645609 [TBL] [Abstract][Full Text] [Related]
10. Mitochondrial DNA in serum of patients with prostate cancer: a predictor of biochemical recurrence after prostatectomy. Ellinger J; Müller SC; Wernert N; von Ruecker A; Bastian PJ BJU Int; 2008 Aug; 102(5):628-32. PubMed ID: 18410441 [TBL] [Abstract][Full Text] [Related]
11. Quantitative real-time RT-PCR assay for PCA3. Väänänen RM; Rissanen M; Kauko O; Junnila S; Väisänen V; Nurmi J; Alanen K; Nurmi M; Pettersson K Clin Biochem; 2008 Jan; 41(1-2):103-8. PubMed ID: 17996198 [TBL] [Abstract][Full Text] [Related]
13. Partin tables: past and present. Khan MA; Partin AW BJU Int; 2003 Jul; 92(1):7-11. PubMed ID: 12823374 [No Abstract] [Full Text] [Related]
14. Staging for prostate cancer: time to incorporate pretreatment prostate-specific antigen and Gleason score? Roach M; Weinberg V; Sandler H; Thompson I Cancer; 2007 Jan; 109(2):213-20. PubMed ID: 17167758 [TBL] [Abstract][Full Text] [Related]
15. Highly specific detection of prostate-specific antigen-positive cells in the blood of patients with prostate cancer or benign prostatic hyperplasia, using a real-time reverse-transcription-polymerase chain reaction method with improved sensitivity. Barbero G; Destefanis P; Procida S; Mandili G; Ulliers D; Ceruti C; Fiori C; Maule MM; Fontana D; Giribaldi G; Turrini F BJU Int; 2008 Dec; 102(11):1566-72. PubMed ID: 18549428 [TBL] [Abstract][Full Text] [Related]
16. Relationships between reverse transcriptase-polymerase chain reaction for prostate specific antigen, survival, and various prognostic laboratory factors in patients with hormone refractory prostate cancer. Gandhok NK; Looney S; Koochekpour S; Sartor O Urol Oncol; 2005; 23(3):163-7. PubMed ID: 15907715 [TBL] [Abstract][Full Text] [Related]
17. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer. Okegawa T; Nutahara K; Higashihara E J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699 [TBL] [Abstract][Full Text] [Related]
18. Heterogeneity in prostate cancer: prostate specific antigen (PSA) and DNA cytophotometry. Krause FS; Feil G; Bichler KH; Schrott KM; Akcetin ZY; Engehausen DG Anticancer Res; 2005; 25(3A):1783-5. PubMed ID: 16033100 [TBL] [Abstract][Full Text] [Related]
19. Repeated negative prostate biopsies with persistently elevated or rising PSA: a modern urologic dilemma. Puppo P Eur Urol; 2007 Sep; 52(3):639-41. PubMed ID: 17451871 [No Abstract] [Full Text] [Related]
20. The role of prostate specific membrane antigen and pepsinogen C tissue expression as an adjunctive method to prostate cancer diagnosis. Antunes AA; Leite KR; Sousa-Canavez JM; Camara-Lopes LH; Srougi M J Urol; 2009 Feb; 181(2):594-600. PubMed ID: 19084862 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]